AGAdam M. Gordon

Adam M. Gordon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam M. Gordon has a total of 156 co-authors. Here are the top co-authors by number of shared publications:

  • Jack Choueka

    Maimonides Medical Center, Brooklyn, NY, USA

    18 shared publications
  • Matthew L. Magruder

    Maimonides Medical Center, Department of Orthopaedic Surgery, Brooklyn, NY, USA

    14 shared publications
  • Charles A. Conway

    Department of Orthopaedic Surgery and Rehabilitation, Maimonides Medical Center, Brooklyn, NY, USA

    8 shared publications
  • Michael A. Mont

    The Rubin Institute for Advanced Orthopedics, Baltimore, MD, United States

    8 shared publications
  • Ramin Sadeghpour

    Department of Orthopaedic Surgery and Rehabilitation, Maimonides Medical Center, Brooklyn, NY, USA

    7 shared publications
  • Afshin E. Razi

    Department of Orthopaedic Surgery

    6 shared publications

Latest Publications

  • Social Determinants of Health Are Associated With 2-Year Implant Complications Following Total Elbow Arthroplasty

    by Adam M. Gordon, Mohamed Said, Patrick P. Nian, Murad Ruzzak, Jack Choueka

    Background: Social determinants of health (SDOH) may influence outcomes after total elbow arthroplasty (TEA), but associations with long-term implant-related complications are unclear. We evaluated the relationship between documented SDOH and: (1) 2-year implant-related complications after primary TEA; and (2) discharge disposition and 90-day health care utilization. Methods: A retrospective matched cohort study was performed using a national insurance claims database (2010-2021). Primary TEA patients with 2 years or more of continuous follow-up were included. Social determinants of health exposure was defined using International Classification of Diseases, Ninth and Tenth Revision codes. Social determinants of health patients (N = 342) were matched 1:5 to controls (N = 1683) by age, sex, and overall Elixhauser Comorbidity Index. The outcomes evaluated included 2-year implant-related complications, non-home discharges, 90-day emergency department (ED) visits, and readmissions. Multivariable logistic regression computed odds ratios (ORs) of each outcome with 95% CIs. Significance was set at P < .01. Results: Social determinants of health exposure was associated with higher odds of 2-year infection (OR, 2.01; 95% CI, 1.35-2.94; P = .0004) and elbow stiffness (OR, 1.74; 95% CI, 1.22-2.43; P = .001), with no significant differences in revision or other implant-related complications. Social determinants of health exposure was associated with higher odds of non-home discharges (OR, 1.82; 95% CI, 1.15-2.82; P = .008), while 90-day ED visits and readmissions were not significantly different between groups. Conclusion: Documented SDOH were associated with increased 2-year infection and stiffness after TEA and higher odds of non-home discharges, without increased revision risk. Level of Evidence: III

  • Association Between Cannabis Use and Tobacco Use With Nonunion of Nonoperative Management of Scaphoid Fractures

    by Adam M. Gordon, Patrick P. Nian, Mohamed Said, Christopher J. Williams, Jack Choueka

    Background: Scaphoid fracture nonunion remains a clinically significant complication after nonoperative management. While tobacco use is a known risk factor, the association between cannabis use and nonunion risk is less well defined. This study evaluated whether cannabis use, alone or combined with tobacco use, is independently associated with increased rates of scaphoid fracture nonunion and subsequent surgical intervention. Methods: A retrospective cohort study was conducted using a national health care database from 2010 to 2021. Adult patients with acute scaphoid fractures initially managed nonoperatively were identified. After inclusion and exclusion criteria were applied, 260 806 patients were analyzed and stratified into 4 groups: non-users (n = 165 699), tobacco-only users (n = 75 504), cannabis-only users (n = 4225), and combined cannabis and tobacco users (n = 15 378). Cohorts were matched for age, sex, and comorbidities. Primary outcomes included scaphoid nonunion at 6, 12, and 24 months and rates of surgical intervention. Multivariable logistic regression was used to evaluate independent associations between substance use and nonunion ( P < .05). Results: Cannabis use was associated with higher nonunion rates. At 12 months, nonunion occurred in 1.9% of non-users, 3.2% of tobacco-only users, 3.9% of cannabis-only users, and 6.2% of combined users ( P < .001). At 24 months, rates increased to 2.0%, 3.6%, 4.3%, and 6.9%, respectively ( P < .001). Multivariable analysis demonstrated increased odds of nonunion among cannabis-only users (odds ratio [OR] = 1.05, P = .043), tobacco-only users (OR 1.27, P < .001), and combined users (OR = 1.43, P < .001). Conclusions: Cannabis use is independently associated with increased scaphoid fracture nonunion following nonoperative management, with a synergistic association observed among combined cannabis and tobacco users.

  • Open Access

    Impact of neighborhood socioeconomic deprivation on implant complications after unicompartmental knee arthroplasty: a propensity-matched cohort study

    by Adam M. Gordon, Patrick Nian, Joydeep Baidya, Michael A. Mont

    Introduction Although previous studies have examined total joint arthroplasties (TJA), research on the association between the Area Deprivation Index (ADI) and outcomes following unicompartmental knee arthroplasty (UKA) remains limited. This study evaluates outcomes following UKA and whether patients with higher ADIs (indicating greater socioeconomic disadvantage) are at increased risk for implant-related complications. Methods A retrospective analysis was performed using a nationwide claims database from 2010 to 2022. The ADI was used to categorize patients into high and low ADI groups. A total of 26,058 primary UKA patients for osteoarthritis were 1:1 propensity-score matched by age, gender, and Elixhauser Comorbidity Index (ECI). Primary endpoints included 2-year implant-related complications and costs. Multivariable logistic regression models computed the odds ratios (OR) for the association between ADI and 2-year implant complications. P values < 0.001 were significant. Results Patients undergoing UKA with higher ADIs experienced no difference in the incidence and odds of implant-related complications within 2 years compared to those with lower ADIs. Periprosthetic fractures were less common in the high ADI group (0.21% versus 0.40%; OR: 0.53, P = 0.008). Periprosthetic joint infections (PJIs) (1.27% versus 1.33%; OR: 0.95, P = 0.701), aseptic loosening (1.14% versus 1.05%; OR: 1.08, P = 0.512), manipulations under anesthesia (MUA) (1.10% versus 0.92%; OR: 1.20, P = 0.153), or all-cause revisions (3.04% versus 2.86%; OR: 1.07, P = 0.378) were similar between groups. Patients in the higher ADI cohort had significantly higher day of surgery ($5,336 vs. $4,118;P < 0.0001) and 90-day costs ($7,462 vs. $6,431; P < 0.0001) after propensity-matching and adjustment for measured comorbidities. Conclusion Patients undergoing UKA of higher ADIs did not experience significant differences in implant-related complications compared to those of lower ADIs. Socioeconomic disadvantage alone is not a major determinant of early implant-related outcomes following UKA. These findings support equitable patient selection and treatment decisions based on clinical indications rather than socioeconomic proxies of patient complexity. Level of evidence III.

  • Cervical disc arthroplasty has higher preoperative costs than anterior cervical discectomy and fusion: a retrospective analysis

    by Adam M. Gordon, Paul G. Mastrokostas, Leonidas E. Mastrokostas, Mitchell K. Ng

    Purpose To assess and compare the preoperative healthcare costs associated with single-level cervical disc arthroplasty (CDA) and anterior cervical discectomy and fusion (ACDF), with additional evaluation across cost categories and insurance types. Methods Patients who underwent CDA or ACDF between 2010 and 2022 were queried from the PearlDiver Mariner database. Preoperative expenditures — including office visits, imaging (X-ray, MRI, CT), opioid prescriptions, steroid injections, and physical therapy — were quantified. Patients were stratified by insurance type, and statistical comparisons were performed using t-tests with significance set at P < 0.05. Results CDA was associated with significantly higher preoperative costs compared to ACDF. The mean total preoperative cost for CDA was $10,967.98 versus $9,463.64 for ACDF (P < 0.001), driven by greater expenditures on physical therapy, imaging, and office visits. Among Medicare beneficiaries, CDA patients had preoperative costs of $9,517.83 versus $9,178.40 for ACDF (P < 0.001), with significant differences in imaging. In the commercial insurance cohort, CDA patients incurred $11,062.86 compared to $9,226.20 for ACDF (P < 0.001), with larger differences in physical therapy, imaging, and office visits. Conclusion CDA incurs higher preoperative costs than ACDF across both Medicare and commercial insurance groups, with notable differences in physical therapy and imaging expenditures. These findings underscore the importance of evaluating cost drivers in the preoperative setting and highlight the potential for cost-optimization strategies, particularly in patients undergoing CDA.

  • Multiple sclerosis is associated with increased shoulder dislocations and aseptic loosening following reverse shoulder arthroplasty: a propensity matched analysis

    by Adam M. Gordon, Jake Schwartz, Ron Gilat, Kevin K. Kang, Jack Choueka, Ramin Sadeghpour

    Introduction Multiple sclerosis (MS) is a chronic neurological condition characterized by muscle spasticity, which may influence the outcomes of reverse shoulder arthroplasty (RSA) for glenohumeral osteoarthritis or proximal humerus fractures. It is unclear whether implant complications and revision rates are increased in patients with MS. The aim was to compare 2-year implant complications and 90- day costs in MS patients undergoing RSA. Methods A retrospective analysis was performed using the PearlDiver database (2010–2022). MS patients (N = 764) who underwent RSA either for glenohumeral osteoarthritis or proximal humerus fractures were identified and matched to patients without MS (N = 3,682) in a 1:5 ratio by age, sex, and comorbidities. Two-year implant complications, including shoulder dislocations, aseptic loosenings, periprosthetic joint infections (PJIs), periprosthetic fractures, and all-cause shoulder arthroplasty revisions, were compared between the two groups using multivariable logistic regressions. Costs were evaluated over a 90 day episode of care interval. P values < 0.05 were significant. Results The proportion of patients who underwent RSA for proximal humerus fracture was not different between patients with and without MS (12.4% vs. 15.1%; P = 0.063). Patients had no difference in overall comorbidity burden (ECI: 8.1 vs. 8.0; P = 0.39). At 2 years, MS patients were associated with significantly higher rates and odds of shoulder dislocations (OR: 1.94, P = 0.006) and aseptic loosenings (OR: 1.93, P = 0.044). There was no significant difference in all-cause revisions (OR: 1.39, P = 0.183), PJIs (OR: 0.72, P = 0.326), or periprosthetic fractures (OR: 1.20, P = 0.773) compared to controls. Patients with MS incurred significantly higher 90 day episode of care costs: $11,437 vs. $10,321; P = 0.0002. Conclusions MS patients undergoing RSA were associated with significantly higher rates of shoulder dislocations and aseptic loosening compared to controls. Additionally, MS patients incurred significantly higher 90-day episode of care costs. These findings underscore the need for careful perioperative planning and long-term monitoring in MS patients undergoing RSA. Level of evidence III.

  • Assessing the Risk Factors for Surgical Site and Deep Wound Infections Following Hip Arthroscopy: A Nationwide Study of 75,577 Patients

    by Patrick P. Nian, Adam M. Gordon, Joydeep Baidya, Andrew Horn, Francis Rosato

    Introduction: The indications and utilization of hip arthroscopic surgery have increased over the past decade owing to advances in surgical technique. Although generally rare, surgical site infections (SSIs) are among the most common postoperative complications following this procedure. This study used a nationwide database to assess the incidence and risk factors for SSIs following arthroscopic hip surgery. Methods: Following a retrospective query of a nationwide administrative claims database for adults (>18 years old) undergoing primary hip arthroscopy from 2010 to 2021, patients were categorized into two cohorts based on whether they did (N = 235) or did not (N = 75,342) develop an SSI within 90 days of surgery. Multivariable logistic regression models were used to calculate odds ratio (OR) of developing SSIs within 90 days following hip arthroscopy, adjusting for age, sex, and comorbidities comprising the Elixhauser Comorbidity Index (ECI). A P value less than 0.05 was considered statistically significant. Results: The overall incidence of SSIs following hip arthroscopy was 0.31%, with no notable change over the study period ( P = 0.697). The two cohorts were similar in age ( P = 0.0716), sex ( P = 0.2959), and geographic location ( P = 0.5995). Overall comorbidity burden was markedly higher among patients who did (ECI = 4.1) versus those who did not (ECI = 2.2) develop SSIs ( P < 0.0001). Risk factors for SSIs following hip arthroscopy included depression (OR: 2.02, P < 0.0001), preoperative fluid and electrolyte abnormalities (OR: 1.81, P = 0.0001), history of drug abuse (OR: 1.74, P = 0.00098), and coagulopathy (OR: 1.58, P = 0.0312). Substratification demonstrated that morbidly obese patients (≥35.00 kg/m 2 ) were more likely to develop SSIs (OR: 4.52, P < 0.0001) compared with patients of normal body mass index. Conclusion: The overall rate of SSIs is low following hip arthroscopy. Certain patient-specific factors may be associated with SSIs and warrant further understanding to prevent these occurrences. This study may guide careful and intentional patient selection and optimization before hip arthroscopy, in efforts to reduce the rate of this event. Level of Evidence: Level III


  • Evaluation of surgeon demographics and association with postoperative complication rates after total hip arthroplasty at the United States News and World Report top-ranked orthopaedic hospitals

    by Adam M. Gordon, Rushabh Vakharia, Michael A. Mont

    Introduction The rankings provided by the U.S. News & World Report (USNWR) are widely consulted to identify leading hospitals. This study aimed to (1) investigate the demographic characteristics of surgeons practicing at USNWR Top-Ranked Orthopaedic hospitals and (2) evaluate if any were associated with complication rates following total hip arthroplasty (THA). Methods The 2009 to 2013 USNWR ‘Orthopaedic’ hospital rankings were curated. Surgeons performing THA and their adjusted postoperative complication rates were compiled using publicly available data from the Centers for Medicare and Medicaid Services (2009 to 2013). Demographic information for each surgeon, including fellowship training, years of practice, age, sex, practice setting, medical degree, residency reputation, case volume, and geographic region, was collected using an internet search algorithm. Logistic regression analyses were conducted to evaluate the association between surgeon demographics and complication rates, with a significance level set at P < 0.008. Results Between 2009 and 2013, a total of 659 orthopaedic surgeons conducted THA procedures at 80 USNWR-top-ranked hospitals. The average case volume for THA was 171 (range: 20 to 1,122), and the average age of surgeons was 50.7 years (range: 32 to 75). A majority of surgeons (56.4%) had completed an orthopaedic surgery fellowship. The mean adjusted 30-day complication rate was 2.2% (range: 1.1 to 4.4%). Surgeon age ≤ 42 years (odds ratio (OR) 3.1; P = 0.006) and lower case volumes (≤ 100 cases) (OR 2.5; P < 0.0001) were associated with higher complication rates. However, sex, geographic region, completion of fellowship, medical degree type, and residency reputation did not show significant associations. Discussion Surgeon-related factors may be associated with complication rates following THA conducted at USNWR Top-Ranked Orthopaedic Hospitals, which could be informative for patients and hospitals assessing quality of care. Level of evidence IV.